Table 3.
Genotype (n) | Weight, g | Baseline, mV | Amiloride, mV | Zero Cl−, mV +50 μM CFTRinh 172* | Δ Lubi 20 μM, mV | Δ 100 μM ATP, mV |
---|---|---|---|---|---|---|
C57Bl/6 (7) | 24.7±0.5 | −4.0±0.71 | −1.6±0.51 | −0.7±0.84 | −6.5±1.8 | −10.0±3.7 |
P = 0.0001 | P = 0.003 | |||||
P = 0.007† |
C57Bl/6 mice (n = 7) underwent NPD testing with zero Cl− solution containing CFTRinh 172 before lubiprostone stimulation.
Application of CFTR inhibitor before the zero Cl− response resulted in near isoelectric PD. The value Δ Lubi 20 μM reflects the difference of the maximal change induced by lubiprostone and the stable zero Cl− value. The Δ 100 μM ATP value is the difference of maximal ATP response and the stable zero Cl− value, which represents the calcium-activated chloride conductance. Significance was tested by paired t-test for each response compared with zero Cl− containing CFTRinh 172.
Paired t-test result for lubiprostone and ATP.